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Abstract
Deep learning with Convolutional Neural Networks has shown great promise in
various areas of image-based classification and enhancement but is often unsuitable
for predictive modeling involving non-image based features or features without spatial
correlations. We present a novel approach for representation of high dimensional fea-
ture vector in a compact image form, termed REFINED (REpresentation of Features
as Images with NEighborhood Dependencies), that is conducible for convolutional
neural network based deep learning. We consider the correlations between features
to generate a compact representation of the features in the form of a two-dimensional
image using minimization of pairwise distances similar to multi-dimensional scaling.
We hypothesize that this approach enables embedded feature extraction and integrated
with Convolutional Neural Network based Deep Learning can produce more accurate
predictions as compared to other methodologies such as Artificial Neural Networks,
Random Forests and Support Vector Regression. We illustrate the superior predictive
performance of the proposed representation, as compared to existing approaches, us-
ing synthetic datasets, cell line efficacy prediction based on drug chemical descriptors
for NCI60 dataset and drug sensitivity prediction based on transcriptomic data and
chemical descriptors using GDSC dataset. Results illustrated on both synthetic and
biological datasets shows the higher prediction accuracy of the proposed framework
as compared to existing methodologies while maintaining desirable properties in terms
of bias and feature extraction.
Index terms— Deep Learning, Convolutional Neural Network, Compact Feature Rep-
resentation, Regression, Drug Sensitivity Prediction.
1 Introduction
In recent years, machine learning has been able to produce numerous insights from the
surge of data generated in diverse areas. For instance, the area of computational biology has
benefited from the availability of high throughput information for genome, transcriptome,
proteome and metabolome. These large datasets often have the issue of numerous features
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with limited samples which necessitates the use of feature selection or feature extraction
prior to modeling. A predictive modeling framework that has high accuracy and incorpo-
rates inbuilt feature extraction or selection can be highly useful in such circumstances. In
pharmacogenomics studies, in order to predict drug efficacy, based on genomic characteri-
zations, various types of machine learning approaches such as Random Forests, Elastic Net,
Kernelized Bayesian Multi Task learning, Support vector Regression have been proposed
[1, 2, 3, 4] where an initial step of feature selection or extraction has been included before
model building.Although, sparse linear regression approaches such as Lasso and Elastic
Net do offer embedded feature selection but the accuracy of the models are significantly
lower than ensemble, kernel and non-linear regression approaches under model misspecifi-
cation [1]. On the other hand, deep convolutional neural networks (CNN) has the potential
to provide high accuracy prediction while automatically discovering multiple levels of joint
representation of the data and thus eliminating the need for feature engineering or selection
[5]. CNN bypasses the a priori manual extraction of features by learning them from data
[6]. Furthermore, their representational richness often allows capturing of nonlinear depen-
dencies at multiple scales [7], and minimizing generalization error rather than the training
error [8].
CNN based Deep Learning methods have shown improved performance in speech
recognition, object recognition [9], natural language processing [10], genomics [11] and
cancer therapy [12]. Deep (multi-layered) neural networks are especially well-suited for
learning representations of data that are hierarchical in nature, such as images or videos
[15]. CNN-based methods have achieved close to human-level performance in object clas-
sification, where a CNN learns to classify the object contained in an image [16]. In the
computational biology area, Alipanahi et al [11] used 1-D CNN architecture to predict
specificities of DNA and RNA binding proteins by directly training on the raw DNA se-
quence. Note that 1-D CNN can be directly applied to scenarios where the features have
relationships with neighbors such as DNA or RNA sequences. However, a 1-D CNN will
not be highly effective in scenarios where ordering of features does not describe the depen-
dencies among features. For instance, gene expressions or chemical descriptors, in their
raw form, do not exhibit any form of ordering and hence not amenable to 1-D CNN.
If, on the other hand, the predictors are in form of images, a CNN model is often
effective because the spatial correlation among the neighbors can be exploited to reduce
the number of model parameters compared to fully connected network by applying con-
volutional operations and sharing parameters. In classification setup, [12] demonstrated
the efficiency of this approach to distinguish the most prevalent subtype of lung tumor
from normal lung tissue using whole slide images of The Cancer Genome Atlas (TCGA)
dataset and validating on independent histopathology images. Thus, the ability to repre-
sent a collection of potentially high dimensional scalar features as images, with correlated
neighborhoods, has the potential of benefiting from the automated feature extraction and
high accuracy predictions of CNN based Deep Learning. To our knowledge, the only other
approach for representing data as images is OmicsMapNet [13] that has been proposed at
the same time while we were developing our REFINED idea. OmicsMapNet uses treemap
[14] to rearrange omics data into 2D images which requires preliminarily knowledge ex-
tracted from KEGG. OmicsMapNet cannot be used when there is no ontology knowledge
on the omics data, or when the covariates are non-omics data such as drug descriptors.
In this paper, we present a novel methodology, termed REFINED (REpresentation of
Features as Images with NEighborhood Dependencies), for representing high dimensional
feature vectors as mathematically justifiable 2D Images that can be processed by standard
convolutional neural network based deep learning methodologies. We illustrate the ad-
vantages of our proposed framework in terms of accuracy and bias characteristics on both
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synthetic and biological datasets.
2 Materials and Methods
In this section we introduce our proposed REFINED algorithm that maps high-dimensional
feature vectors to images, describe the datasets used for performance evaluation, followed
by the CNN architecture used as the predictive model.
2.1 REpresentation of Features as Images using NEighborhood De-
pendencies (REFINED)
As mentioned earlier, the main idea of the REFINED CNN approach is to map high-
dimensional vectors to mathematically justifiable images for training by traditional CNN
architecture. Evidently, a mapping of features from the high dimensional vector to a 2-D
image matrix serially in a row by row or column by column fashion will not guarantee any
spatial correlations in the image. Instead, we first obtain the euclidean distance matrix of
the features and use it as a distance measure to generate a compact 2D feature representation
where neighborhood features are closely related. A potential solution to achieve this 2-D
projection is to apply dimensionality reduction approach such as Multidimensional Scaling
(MDS) [20] on a distance measure such as euclidean distance of features. However, that
will not guarantee that each mapped point will have a unique pixel representation in the
image and might result in sparse images due to the overlap [21]. For instance, if we have
900 features, the features can potentially be represented by a 30× 30 matrix and a direct
MDS like approach on a 30×30 dimension space might not spread out each feature in such
a manner that each pixel contains at most one feature. To ensure that the features are spaced
out in a discrete grid and to incorporate the discrete nature of the image pixels, we apply
a Bayesian version of metric MDS. We start with the MDS algorithm to create an initial
feature map (a 2-D space with feature coordinates) that preserves the feature distances in
the 2-D space with minor computational cost. Next, we apply the Bayesian MDS (BMDS)
to estimate the feature location on a bounded domain with the constraint that each pixel
can at most contain one feature. However, the location of the features are estimated up to
an automorphism. Therefore, we apply a hill climbing algorithm, with a cost function that
measures the absolute difference in the Euclidean distances among the new feature loca-
tions (as represented by the 2D image map) to the estimated true distances (δˆ , anticipating
the following section) among the features, to arrive at an optimal configuration.
More specifically, starting from the BMDS location estimates, we considered all the
configurations in the map sequentially in row-order. For each feature, we tried different
permutations of the features by interchanging the position of the central feature position
with its neighboring features and selected the permutation that minimizes the above men-
tioned cost function. Once the cost function is minimized, a set of unique coordinates in a
2D space was produced for each feature. Using those coordinates, we mapped the features
into a 2D space and create an image per sample. The created images were then used to
train the REFINED CNN.
The general idea of the REFINED CNN approach is shown pictorially in Figure 1 for
the application case of predicting drug efficacy over a cell line using genetic characteristics
of cell lines and chemical descriptors of the drug as predictors.1 In Figure 1, an example
case is shown where F-12 has been interchanged with its neighboring features, and after
1Note that we use PaDEL features as chemical descriptors of each drug.
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each exchange, we checked the similarities/correlation among distances of features from
the map and estimated distance matrix of descriptors. If we can find a better exchange
case in the feature map, we exchange that feature pair and arrive at a new feature map.
The entire process was repeated iteratively until we reached the optimized feature map that
is close to the benchmark distance matrix (δˆ ) of the initial features (in this case PaDEL
descriptors).
At the conclusion of this iterative algorithm, we arrive at a REFINED feature map
with all features having a unique position in a bounded 2-D space and similar features are
placed close by and dissimilar features are far apart. Without loss of generality, we have
considered feature maps on unit square and the BMDS specification induced sparsity in the
image.
Figure 2 shows some generated REFINED images for different drugs. Each image
varies from another depending on the value of the PaDEL descriptors of the drug, but the
descriptor coordinates are same for all the cases.
2.1.1 Theoretical Basis for REFINED
Consider the predictor matrix X = {xi j}, i = 1,2, ...,n; j = 1,2, ..., p with xi j being the
value of the jth predictor for the ith subject. Suppose, the predictors are generated from a
latent zero mean, square integrable stochastic process {Z(s)} where the index s belongs to
a compact subset of Rm. Let s j denote the original position of the jth predictor produced
by Z(s) and the observed data is randomly permuted version of the original data, i.e. xi j =
Zi(s j).
Case 1: There is a underlying true ordering of the predictors , i.e., there exists a per-
mutation {pi(1), ...,pi(p)} of {1,2, ..., p} such that spi(1) < spi(2) < ... < spi(p) is the true, but
unknown, ordering of the predictors. If such ordering exists, we can take m = 1 and the
predictors can be projected on [0,1] via unidimensional scaling (UDS). Let {sˆ1, ..., sˆp} be
the estimated locations of the p predictors on [0,1] obtained via UDS. Let {ψ(1), ...,ψ(p)}
be the permutation of {1,2, ..., p} that orders {sˆ1, ..., sˆp}. Then under some regularity con-
ditions ψ( j) = pi( j), 1 ≤ j ≤ p, ∀p. Thus UDS can correctly identify the true relative
pairwise distances among the predictors.
For proof, see [32].
Case 2: Suppose the ordering does not exist. For example, suppose three predictors are
equidistant from one another. Clearly, m = 1 may not be a valid assumption and results
corresponding to Case 1 become untenable in this situation. For the second order approx-
imation, we start with m = 2, i.e., we would like to obtain the location of the predictors in
a compact subset of R2. Without loss of generality, we project the locations on unit square
([0,1]2).
Let d jk be the observed distance between the jth and the kth predictor and δ jk be
their true, but unobserved, distances. Under the assumption of Euclidean metric,δ jk =√
∑l(s j,l− sk,l)2, where s is now 2D coordinate system denoting the true location of the
predictors j and k in unit square. As in Case 1, we can assume that pi(.) is the underlying
true permutation of 2D configurations of the p predictors. Our goal is to draw inference on
the locations of each predictor, i.e. estimate s j ∈ [0,1]2.
[33] developed a Bayesian estimation procedure to estimate s based on observed dis-
tance by assuming d jk ∼N(δ jk,σ2)I(d jk > 0) at the data level. For the location process, we
specify a spatial Homogeneous Poisson Process (HPP) with constant intensity λ = p/[0,1]2
which essentially distributes locations of p predictors randomly in an unit square. Since
this corresponds to complete spatial randomness, an alternative specification of location
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STAGE I
STAGE II
STAGE III
Initial Image 
step (0) : Feature Map
BMDS
REFINED Image
CNN
VectorizationConvolution + Pooling Layers
Fully Connected Layers
Prediction
𝑹 𝒌 < 𝑹𝐦𝐚𝐱 Permutation
REFINED Core
𝑹 𝒌 = 𝑹𝐦𝐚𝐱
step (k-1) : Feature Map
step (k) : Feature Map
Optimal Feature Map
Figure 1: Overview of training a CNN using REFINED images which mainly transforms
cell line-drug pairs data structures into images, (STAGE I) distance matrix of the 672
PaDEL descriptors of the cell line-drug pairs are used to calculate the distance between
features, (STAGE II) Initial BMDS images generated using the initial distance matrix,
then hill climbing algorithm utilized as an iterative optimizer to maximize the correlation
between features, by relocating the features (descriptors) in the distance matrix. (STAGE
III) A CNN is trained using REFINED images and drug responses of the 60 drugs of NCI60
dataset to predict drug sensitivity of paired cell lines.
Figure 2: Illustration of generated images randomly selected from the NCI60 dataset, where
the caption denotes the method that is utilized to generate the image followed by the NSC
ID associated with the image.
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process is given by s = {s1,s2, ...,sp} ∼Uni f orm([0,1]2) [38]. Note that, the properties
of HPP guarantee that the HPP operating on the unit square can be further partitioned into
disjoint cells and the entire location process can be expressed as the superposition of the
HPPs operating on these disjoint cells. Futhermore, as the volume of each cell (within the
unit square) goes to zero, so does the probability of observing more than one event in that
cell [35]. We also note that, we do not assume that the location process shows any clus-
tering tendency a-priori, however the uniform specification is flexible enough to capture
clustering a-posteriori [38]. Let us denote the set of observed and true distances by d and
δ , respectively. Our data model is then given by
f (d |s,σ2) ∝ (σ2)−q/2 exp
[
− 1
2σ2 ∑j>k
(d jk−δ jk)2−∑
j>k
logΦ(δ jk/σ)
]
(1)
where q=
(p
2
)
is the total number of distances in the dataset and Φ(.) is the usual standard
normal cdf. At the process level, we have
s|p∼Uni f orm([0,1]2) (2)
Finally, the prior is given by σ2 ∼ IG(a,b) with a > 2, b > 0 and IG denoting the Inverse
Gamma distribution. Consequently, the full posterior distribution is given by
[s,σ2|d ] ∝ (σ2)−(q/2+a+1) exp
[
− 1
2σ2 ∑j>k
(d jk−δ jk)2−∑
j>k
logΦ(δ jk/σ)−b/σ2
]
(3)
When q is large, ∑ logΦ(.) ≈ 0, the full conditional posterior of σ2|. is approximated by
IG(q/2+a, 12 ∑ j>k(d jk−δ jk)2+b). However, the conditional posterior of s is not available
in closed form, a Metropolis-in-Gibbs sampler is used to obtain posterior realizations of
the locations. Since s are identifiable only up to an automorphism, convergence of the
Markov Chain Monte Carlo (MCMC) is assessed on δ and σ2. Furthermore, following
the recommendation of [33], we used the posterior mode of s as the point estimate of the
predictor location.
Once these locations are estimated, we have a set of point-referenced predictor location
in the domain of interest. The domain is then subjected to regular square tessellation such
that each pixel contains at most one location – essentially rewriting the point process a-
posteriori as superposition of constant intensity local point processes operating on disjoint
cells that the unit square in partitioned into. Additionally, the constraint of allowing at most
one predictor location per-pixel implies that the posterior location process is approximated
by a Non-homogeneous Poisson process [35]. The foregoing hill climbing algorithm is
then applied to arrive at locally optimal configuration 2.
Once the tiled surface associated with the feature space is obtained, we have the ob-
served value, x(s j), for each row of X . The intensity at each pixel is, therefore, determined
by x(s j). Pixels that do not contain any predictor location are assigned null values. This
pixelated image on unit square is our second order approximation of the random functions
developed in [32]. We can then deploy any suitable smoothing operation (for example, au-
toregressive spatial smoothing [34]) to generate the corresponding predictor images (such
as shown in figure 2). Furthermore, each posterior realization of s can be used for data aug-
mentation purpose in CNN architecture. Also, since Euclidean metric is invariant under
2The location process is not uniquely identifiable. Local adjustment via hill climbing is done to mimic
the swapping step of the partition-around-medoid algorithm.
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translation, rotation and reflection about the origin, any such perturbation will not affect
the relationship between the response and predictors.
Note that, even if there exists ordering among the covariates, we can still generate these
images in the following way. Since [32] guarantees that the relative pairwise distances
among the predictors, estimated from UDS, are consistent estimators of the true relative
distances, we can posit a calibration model for these estimates dˆ jk to connect with the true
distance, i.e. dˆ jk ∼ N(α0+α1δ jk,σ2)I(d jk > 0).
2.2 Datasets and Preprocessing
To evaluate our framework, we considered three datasets: (a) A synthetically generated
dataset (b) NCI 60 dataset consisting of drug responses following application of more than
52,000 unique compounds on 60 human cancer cell lines [22] (c) Genomics of Drug Sensi-
tivity in Cancer (GDSC) [24] dataset that contains responses to 222 anticancer drugs across
approximately 972 cancer cell lines with known genomic information. In scenario (b), we
use the chemical descriptors of drugs to predict drug responses in a specific cell line. In sce-
nario (c), we consider two heterogeneous predictor set- (i) gene expressions for cancer cell
lines and (ii) chemical descriptors for applied drugs and use both these type of predictors
to predict drug responses .
(a) Synthetic dataset
We simulated a synthetic dataset with P correlated features for N samples, where for each
simulation 20%, 50% and 80% of the features were spurious. The features were simu-
lated from a zero mean Gaussian process with stationary isotropic covariance matrix whose
(i, j)th element is given by γ |i− j|. P ranged from 20,50,100,400,800,1000,2000,4000 and
for each P, the number of simulated sampled ranged from 50,200,600,1000,2000,5000,10000.
We simulated the target values by simply multiplying random weights to the features. For
example, N target values with 100 features (X N×100), with 20% spurious features were gen-
erated using the relation X [β r,β 0]T where β
80×1
r are non-zero random weights and β
20×1
0
are zeros.
(b) NCI dataset
The US National Cancer Institute (NCI) screened more than 52,000 unique chemicals on
around 60 human cancer cell lines. The chemical (drug) response is reported as GI50
which is the concentration required to achieve 50% of maximal inhibition of cell prolifer-
ation [22]. All the chemicals have an associated unique NSC identifier number which is
assigned to identify agents when they are submitted for clinical trials to the Cancer Therapy
Evaluation Program (CTEP). We used the NSC identifiers to obtain the chemical descriptor
features and then used PaDEL software [23] to extract these features for each one of the
chemicals. The chemicals with more than 10 % of their descriptor values being zero or
missing were discarded. The final dataset consists of 52,126 chemicals, each with 672 de-
scriptor features and 59 cancer cell lines. To incorporate the logarithmic nature of dose ad-
ministration protocol, we calculated the negative-log concentration of GI50s (NLOGGI50).
The drug response distribution for one illustrative cell lines is shown in figures 3 (a). We
selected 17 cell lines with more than 10k drugs, to ensure availability of enough data points
for training deep learning models. The number of drugs applied on each selected cell line
are provided in table 5 of the appendix. All these preprocessing steps were conducted on
the training phase.
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Figure 3: (a), (b) Drug response distribution of SNB 78 and COLO 205 cell lines of NCI60
dataset in natural logarithmic scale, where all the cell lines response distribution with more
than 10,000 samples have the same large peak, (c) represents the drug response distribution
in natural logarithmic scale of all the drugs that had been applied on all the cell lines
available in the GDSC dataset.
(c) GDSC dataset
For validation of our framework, we also considered the Genomics of Drug Sensitivity in
Cancer (GDSC) [24] dataset which describes the responses to 222 anticancer drugs across
approximately 972 cancer cell lines. The resulting drug-cell line pairs have the responses
reported in the form of IC50 which denotes the concentration of the drug to reduce the
response by 50%. The normalized drug response distribution is shown in figure 3(c). We
used the gene expression of the cell lines data (17,737 genes), and PaDel descriptors of drug
data as predictors. Descriptors with more than 10 % zero or missing values were removed
from the dataset, and the rest of missing values were imputed using KNN. Finally, 171K
drug-cell line pairs (953 Cell lines, and 206 Drugs) are available for training.
Since in prior drug sensitivity studies [1] [2] [27], an initial feature selection was used to
reduce the number of genes before training the predictive model, we also used an a-priori
RELIEFf based feature selection [28] for scenario (c) for easier comparison with earlier
studies. Since multiple drugs were tested on each cell line, a common subset of 1211 genes
were selected that were found to be common among top 8048 ∼ 8000 genes selected for
each drug. Similar to NCI60 scenario, we used PaDEL software to obtain the chemical
descriptor features. The chemical descriptors with more than 10 % of their descriptor
values being zero or missing were discarded. Finally each drug has 992 descriptors as
features. The gene selection process was conducted on the training set, then the same set
of genes were used for validation and test. All the gene expressions and drug descriptors
were normalized between 0 and 1.
2.3 Predictive Models
We used the REFINED images to train a CNN regressor to predict drug sensitivity of
the NCI60, and GDSC datasets, as well as the simulated target values of the synthetic
datasets. We compared performance of the REFINED CNN with Random Forest (RF),
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Support Vector Regressor (SVR), a deep Artificial Neural Network (ANN) for synthetic
dataset. For other datasets, along with RF, SVR, and ANN, we compared the REFINED
CNN with Elastic Net (EN), CNN with images created by random 2D projection matrix
(Random CNN), and CNN with images created using principal component analysis (PCA
CNN) coordinates. The details on Random CNN and PCA CNN are included in section
3.1. We randomly picked 17 cell lines where each cell line contained more than 10k drug
responses so that we have sufficient number of samples to train a deep learning model.
Subsequently, 17 set of models were trained to predict NLOGGI50 of drugs tested on the
selected cell line. In each set, all the above-mentioned models were trained on the same set
of samples and tested on a separate set of same samples.
Note that for the synthetic dataset and the NCI60 dataset, the predictors are a vector
of real values (chemical descriptor values for NCI60) that are converted to images. For
the GDSC dataset, we have two types of input features: chemical descriptors describing
the drugs and gene expression describing the cell lines. We generated individual images
for each feature type and used both of them as inputs to the CNNs. For the RF, SVR,
ANN, and EN these two types of features were appended and used as the predictors. We
trained REFINED CNN and 6 other competing models on same set of samples, where each
sample is a combination of one drug tested on one cell line. All the models were tested on
a separate set of same samples.
The distribution of NLOGGI50 shows a massive point mass at 4 (Figure 3 (a) and (b))
indicating that an overwhelming majority of drugs are not sensitive for majority of the
NCI60 cell lines. Thus, we also considered a classification problem of whether a drug is
sensitive or resistive among the NCI60 cell lines. Based on the NLOGGI50 distribution
for different cell lines, the sensitivity threshold was empirically fixed at 4.5. All the drugs
with NLOGGI50 less than the threshold (4.5) were considered resistive and the rest as
sensitive. Similar to the regression scenario, we compared the CNN performance with RF,
SVM, ANN, logistic regression (LR), Random CNN, and PCA CNN for the classification
scenario.
2.3.1 Convolutional Neural Network
Convolutional Neural Networks (CNN) are designed to model multidimensional arrays,
where convolutional layers along with pooling layer, are adaptive feature extractors con-
nected to sequential fully connected layers [6]. A convolutional layer consists of multiple
kernels connected to a local path of neurons in the previous layer, where all neurons share
same parameters to generate a feature map. Thus, all neurons within the feature map scan
same features in different locations of the previous layer. The pooling layer summarizes
the feature map by finding the maximum/average of each adjacent kernel, which reduces
the number of model parameter [5]. We used two different CNN architectures, a sequential
CNN for modeling the NCI60 and synthetic dataset, and a hybrid CNN, that can accom-
modate drug and genetic image for the GDSC datasets.
The sequential CNN regressor contains six learned layers: one input layer, two convo-
lutional layer, two fully connected layer and one output layer. The CNN input dimension
is same as the input image dimension, 26×26. The convolutional layer contains 64, 7×7
kernels convolving with valid border mode and stride of 2, followed by batch normaliza-
tion, and ReLu activation. Each fully connected layer is followed by a batch normalization
layer and ReLu activation layer. Number of neurons of the fully connected layers are re-
spectively, 256, and 64. A dropout layer with retaining probability of 0.7 was added before
the output layer. The above architecture remains same for Random CNN, PCA CNN and
REFINED CNN.
9
The sequential CNN classifier contains input layer with the same size as the CNN re-
gressor, three convolutional layer with 16 kernels of size 7× 7, 32 kernels of size 7× 7,
and 64 kernels of size 3×3. Each convolutional layer is followed by a batch normalization
[54] and a rectified linear unit (ReLu) [53] activation function layer. The third ReLu layer
is followed by two fully connected layers with 256 and 64 neurons respectively. Same as
the CNN regressor, each fully connected layer is followed by a batch normalization, ReLu
and a drop out layer. The CNN classifier architecture remains same for Random, PCA and
REFINED CNN. We used adam optimizer to train both the CNN regressor and classifier.
The CNN regressor and classifier architecture is shown in figure 37 of the appendix.
We used hybrid CNNs with two inputs to model GDSC dataset, where two separate im-
ages are used as inputs to the two arms of the CNN. Each arm contains three convolutional
layers, where the last convolutional layers are concatenated, and followed by two sequen-
tial fully connected layers. The two input layers represent the cell lines and drug images,
which defines each convolutional layer dimension. The three convolutional layer of each
arm have 60 kernels with the size of 5×5 and stride of 1, 72 kernels with the size of 6×6
and stride of 2, and 72 kernels with the size of 5× 5 respectively. The last convolutional
layer of the arm that takes drug images as the input has stride of 1 and the other arm that
takes cell images as the input has a stride of 2. Each convolutional layer is followed by
batch normalization and ReLu activation function layers. The last two convolutional arms
of the CNN are concatenated and connected to two sequential fully connected layers with
305 and 175 neurons. A batch normalization and a ReLu activation function is included
after each fully connected layer. A dropout layer with retaining probability of 0.7 is placed
before the output layer. The CNN model architecture is shown in figure 38 of the appendix.
The hybrid CNN was trained by an adam optimizer. The same architecture was utilized
for Random, PCA and REFINED images. There are some variations in the architecture
depending on the training set size that are explained in section 3.4. All tuning parameters
were chosen via a comprehensive search that is detailed in the next section.
2.3.2 Hyper parameter search
To tune the competitive models, we did a grid search on the following hyper parameters
for each model using hold-out for partitioning the data. We randomly partition both NCI60
and GDSC data to 80 % training, 10 % validation and 10 % test. The same training,
validation and test datasets were used for all models. The hyper parameters were tuned
using the training and validation sets. The test sets were hold out for evaluating the final
performance of each tuned model.
• RF: The number of decision trees in the forest ranged from 100 to 700 trees. For the
maximum number of features for the best split evaluated at each node, we tried all
the options provided by scikit-learn [52] including: number of features, square root
of number of features, and logarithm base 2 of number of features.
• SVM: Gamma parameter of the radial basis function (RBF) kernel using both ’scale’
and ’auto’ options of scikit-learn, and the regularization parameter, ’C’, ranging from
0.01 to 100.
• EN and LR: Alpha penalty term and L1 ratio values between (0.3,0.7) and (1e-6,1e-
4), respectively.
• ANN: Number of hidden layers (3-6), number of neurons per each hidden layer and
learning rate of the Adam optimizer.
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– 1 hidden layer: 800-1200 neurons
– 2 hidden layer: 600-1000 neurons
– 3 hidden layer: 400-700 neurons
– 4 hidden layer: 200-500 neurons
– 5 hidden layer: 50-250 neurons
– 6 hidden layer: 20-80 neurons
– learning rate: 1e-6 - 1e-3
• CNN: As we did not have access to GPUs, we did not do comprehensive hyper pa-
rameter grid search for the CNNs. The current parameters were chosen over about
hundreds of run. The hyper parameter space that we searched was number of con-
volutional layers, number of dense (fully connected) layers, and the learning rate of
the Adam optimizer. In each convolutional layer, we seek optimum number of ker-
nels, kernel size, and stride. Per each dense layer, we checked multiple number of
neurons. The insights that we gained from thousands of runs are as follows:
– We observed that 7× 7 kernels were better than smaller kernels of 3x3 for the
convolutional operator. For larger number of features, larger kernels might be
desirable.
– Using strides larger than 1 is more effective in embedded dimensionality reduc-
tion than the pooling layer.
– Using two or more sequential convolution layers with kernel size of 7× 7 and
stride of 2 reduces the feature map dimension considerably compared to the
input image. Therefore, large number of kernels is recommended at least for
the last convolution layer, to provide sufficient number of extracted features for
the dense layer.
– The width of network is as important as the depth of the network.
– The Adam optimizer is recommended.
For unbiased evaluation of machine learning models, nested cross-validation [51] (CV)
is often considered where an inner CV is used for model selection (hyper parameter se-
lection) and an outer CV is used for evaluating the model tuned by the inner CV. How-
ever, nested CV is often extremely computationally intensive and thus we considered a
training-validation-test (hold-out) approach where the hyper-parameters are tested on the
validation set and the selected model is evaluated based on the separate test set. We
used training-validation-test approach as the sample size is relatively large and thus, both
training-validation-test and nested CV approaches are expected to provide similar results
for comparing different modeling approaches. To illustrate the similar behavior, we com-
pared the results of nested CV and training-validation-test (hold-out) approach using three
cell lines randomly selected from the NCI60 dataset. As the results provided in figure 18
indicates, the difference in the results are minimal. On the other hand, to compare the time
complexity of the two approaches, we selected one cell line with a fixed CNN architec-
ture. Within the CNN architecture, a grid of hyper parameters was defined. In a single
run (architecture) that takes 48 hours on Texas Tech University high performance com-
puter center, 50 different models can be tried using training-validation-test, whereas only 4
models can be tried using nested cross-validation. Given the time complexity and similar
performance of the two approaches, we used training-validation-test approach for hyper
parameter selection and model evaluation as we could search considerably larger space of
hyper parameters.
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3 Results
In this section, we report the performance of our REFINED-CNN methodology on the
previously described synthetic, NCI60, and GDSC datasets. In each case, the performance
of the REFINED CNN was compared to ANN, RF and SVR models. We also compared
the REFINED CNN with EN, Random CNN, and PCA CNN for biological datasets.
Evaluation Metric: We evaluated the performance of each regression model using (a) nor-
malized root mean square error (NRMSE), (b) Pearson correlation coefficient (PCC) be-
tween the predicted and target values and (c) bias reduction. The NRMSE (4) is the ratio
of the root mean squared error (RMSE) of a given model to the RMSE with mean as the
predictor. It represents the overall potential of the model to minimize prediction error.
NRMSE =
√
∑Ni=1(yi− yˆi)2
∑Ni=1(yi− y¯)2
(4)
where the y, y¯ , and yˆ are respectively the target data, mean of the target values, and pre-
dicted target values. We offer NRMSE in order to implicitly compare all the models with
respect to the baseline intercept-only model.
PCC indicates collinearity between the predicted and observed responses. Lack of
collinearity often implies model misspecification and lack of predictive capability.
To represent the bias, we first generated the scatter plot of the residual (ordinate) and
the observed response (abscissa). We captured the bias via the angle (θ ) between the best
fitted line through the residuals and the abscissa. An unbiased model is expected to produce
an angle of 0◦. Therefore, a smaller value of θ indicates that the model is less biased.
We used Gap statistics [41] to report the significance of the difference in performance
across methods of the regression tasks. We paired each model with a null model [1] with
bootsrap sampling, where the bootstrap sampling was done on the dose-response values
of the test set along with their corresponding predicted values for each model and the null
model randomly predicted dose-response values for the sampled test set using the distri-
bution of the training set dose-responses. The process is repeated for 10,000 times and a
distribution of NRMSE, PCC, and Bias, is made for each model along with the null model.
The distribution per each metric for each model is paired with null models’ metric distribu-
tion. Then cluster centroids are calculated using K-means (k = 2) clustering, after the Gap
statistics shows appropriateness of using 2 clusters. The difference between each model
and the null model cluster centroids per metric represents the difference between them. In
addition to the Gap statistics, all models were subjected to a robustness analysis [1], where
we calculate how many times the REFINED CNN outperforms other competing models in
10,000 repetition of bootstrap sampling process.
We calculated 95 % confidence interval for each metric that is used to measure the
performance of the methodologies in modeling NCI60 and GDSC dataset using a psuedo
Jackknife-After-Bootstrap confidence interval generation approach [4, 31]. Multiple Boot-
strap sets were selected from the test samples and error metrics generated resulting in a
distribution for each error metric which was used to calculate the confidence interval for a
given cell line for NCI60 dataset or a given pair of cell line and drug for the GDSC dataset.
The classification models that predict the sensitive and resistive drugs applied on the
NCI60 data cell lines, were evaluated using accuracy, precision, recall, F1 score, and area
under the receiver operating characteristic curve (AUROC) metrics. Accuracy is the ratio
between correct predictions; true positive (TP) and true negative (TN), over all the predic-
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tions; summation of TP, TN, false positive (FP), and false negative (FN).
Accuracy =
T P+T N
T P+T N+FP+FN
(5)
Precision is the ability of predicting positive instances of the classifiers, or in other
words, the ratio of correctly predicted positive instances.
Precision =
T P
T P+FP
(6)
Recall or true positive rate (TPR) is the ability of the classifiers in predicting positive
instances, which corresponds to the proportion of of positive instances that are correctly
predicted as positive.
Recall =
T P
T P+FN
(7)
F1 score is simply harmonics mean of the precision and recall,
F1score =
2T P
2T P+FP+FN
(8)
False positive rate (FPR) is a ratio between negative instances that are mistakenly pre-
dicted as positive instances. AUROC combines TPR and FPR in many different threshold
for each classifier on a single curve, where the area under the curve is considered as AU-
ROC.
FPR =
FP
FP+T N
(9)
The 95 % confidence interval of each of the above-mentioned classification metrics was
calculated using the Binomial proportion confidence interval [42, 43].
3.1 Comparison with other image generation methods
In this section, we consider two alternative image generation methods for comparison pur-
poses: random projection-based and PCA-based. In the random projection method, we
assume each image is a matrix and the location of each entry in the vector is randomly
mapped to a location in the matrix. Thus, we placed each element of the drug descriptors
or the gene expression on the image (matrix) coordinates one after another.
Principal component analysis (PCA) [26] is mainly used for dimensionality reduction
and visualization purposes, where each sample could be represented on a 2D plane aligned
with their first two principal eigen vectors. The first two principal components of the trans-
posed covariance matrix with rows being features and columns representing samples, were
selected as the feature coordinates. Some of the generated images using the random and
PCA methods are shown in figure 2.
3.2 Synthetic Data
In this section, we offer the comparative performance of the candidate models on the sim-
ulated dataset. First we generate a lexicographic ordering of P features. The features are
then generated from a 0 mean Gaussian process with covariance depending only on the
lexicographic distance between the features. In each case, a subset of features were ran-
domly selected as spurious. Subsequently, random weights generated for non-spurious
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features were used to generate the target values. The generated target values were normal-
ized between 0-1. We have used REFINED to generate images for different N/P scenarios
and then trained a CNN for each scenario. In each case, the same dataset was used to
train RF, SVR and ANN for comparison. We used five-fold cross validation for all the
models on fixed training, validation and test sets. The results are summarized in figure
4, as heat maps. As shown in figure 4, the green regions represents the cases where the
REFINED-CNN NRMSE is less than the competing models. The separate heatmap for all
the model results are provided in the figures 13,14,15,16 of the appendix. The heat maps
clearly shows, that the REFINED-CNN methodology outperforms others when the number
of features and samples are relatively high (P > 100,N > 600) regardless of the percentage
of spurious features present in the dataset. We also observe that the performance of the
posited methodology improves as the N increases. [32] also reported that the performance
of their UDS based projection improved with increase in both N and P. Therefore, our
findings suggest that our second order REFINED approximation are in agreement with the
first order stringing approximation of [32]. Furthermore, we also observe that as the ratio
of spurious features increases, the predictive performance of our REFINED-CNN also im-
proves as compared to the competing models. Recall, we are not performing any feature
pre-selection for REFINED-CNN for the synthetic data. This exercise demonstrates the
ability of our approach to automatically remove spurious features without performing an
explicit feature selection a-priori. Additionally, by comparing the REFINED CNN versus
ANN heatmap we observe that increasing the number of samples reduces the gap between
their performance as more samples are available to train the large number of parameters of
ANN.
We next investigated the effect of the REFINED-CNN approach on the bias characteris-
tics of the prediction. Figure 17 shows the scatter plot of prediction versus actual responses
of the four models when 80 % and 20 % of the features are spurious. Clearly, the scatter
plot for REFINED-CNN closely follows a straight line with unit slope indicating predictive
accuracy of our approach. RF and SVR reveal their well-known tendency to under-predict
higher valued observation and over-predict lower valued observations [17]. REFINED-
CNN bias is also better than the bias observed for the ANN scenario. Thus, it appears that
the REFINED-CNN approach can automatically improve the prediction bias which some
of the other existing models are known to suffer from.
3.3 NCI60 dataset
3.3.1 Classification
We investigated the discriminative power of REFINED-CNN as compared to other models
in predicting resistant and non-resistant drugs on different cell lines of the NCI60 dataset.
The threshold for defining resistant and non-resistant classes, was selected based on the
drug response distribution shown in figure 3. The drugs with NLOGGI50 smaller than
4.25 was considered resistant and the rest as non-resistant. Since, we have sufficiently large
number of drugs for each cell line 3, we randomly considered 80% of the drugs for training,
10% for validation and 10% for testing. As shown in the figure 5, the REFINED CNN
outperforms other classifiers for all 17 cell lines. The average classification accuracy of
REFINED-CNN was 75.4% - considerably higher than the average classification accruacy
obtained for Random CNN (71.6%), PCA CNN (71.7%), ANN (70.3%), RF (70%), SVM
(69%) and LR(67.9%). For each model, we also report precision, recall, f1-score, and
AUROC. REFINED-CNN outperforms other models considering all the metrics. Detailed
3Each unique drug for a particular cell line is a sample in this scenario
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Figure 4: NRMSE difference of REFINED CNN with RF, SVR and ANN for different
sample sizes and with different number of features where the 20 %, 50 % and 80 % of the
features are respectively spurious. The green regions of each heatmap represents where
REFINED CNN outperform other models.
classification results are provided in appendix tables 6, and 7. The 95 % intervals for each
metric for different cell lines are provided in table 9 of appendix.
Figure 5: Summary of REFINED-CNN and 6 other competing classifier models perfor-
mance on randomly selected cell lines of NCI60 database, using the accuracy, precision,
recall, f1-score, and AUROC metrics.
To compare the statistical significance of the difference in performance between com-
peting classifiers and REFINED CNN, we used the McNemar’s test which is a paired
nonparametric statistical hypothesis test. McNemar’s test evaluate whether two models
disagree in the same way or not. To compare classifiers with REFINED CNN classifier
pairwise, a contingency table is formed and McNemar’s test is applied [40]. The null hy-
pothesis is whether two classifiers disagree by the same amount. Therefore, if the p-value
is smaller than a threshold (0.05), null hypothesis is rejected, and the conclusion is: there is
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a significant disagreement between the two classifiers. The results of comparing REFINED
CNN with other models using McNemar’s test is provided in table 8 of the appendix. We
observe that the REFINED CNN classifier performance is significantly different than the
other classifiers (LR, RF, SVM, ANN, Random CNN, PCA CNN).
3.3.2 Regression
The NCI60 dataset was randomly partitioned into 80% , 10% , and 10% segments for
training, validation and test purpose, respectively. The same training, validation and test
set were used for model comparisons. The performance of each model was evaluated using
normalized root mean square error (NRMSE), Pearson correlation coefficient (PCC), and
bias.
Table 10 in the appendix details the performance of each model with respect to the
foregoing metrics for different cell lines. Table 10 is summarized in figure 6, as bar plots.
The 95 % confidence interval for all the models per each cell line is provided in the figure
20 21 22 of the appendix. We note that CNN outperforms all the competing models in all
17 cell lines. The average improvement in NRMSE, PCC and bias for REFINED-CNN as
compared to other competing models are 6-20%, 8-36%, and 12-38%, respectively .
Figure 6: Summary of REFINED-CNN and 6 other competing regressors models perfor-
mance on randomly selected cell lines of NCI60 database, using the NRMSE and Pearson
correlation coefficients metric.
We used Gap statistics and robustness analysis as described in the evaluation metric
section to compare REFINED CNN with other competing models for the regression task.
The robustness results are provided in table 11 of the appendix which indicates that RE-
FINED CNN has better performance in terms of: NRMSE between 89.51-100% of the
times, PCC between 94.42-100% of the times, and Bias 91.14-100% of the times on av-
erage as compared to other models. The Gap statistics results are provided in table 12 of
the appendix, which indicates superior performance of REFINED CNN as compared to the
other models in all the metrics both in average and per each cell line. The NRMSE and
PCC distribution of all the seven models along with the null model are plotted for three cell
lines of the NCI60 dataset in figure 19 of the appendix.
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3.3.3 Data Augmentation
This section analyzes the effect of augmenting the dataset using samples from the less
represented regions. As shown in figure 3(a), the massive point mass associated with the
non-sensitive (resistant) drugs severely impacts a global regression model for NLOGGI50.
This problem is analogous to zero-inflation problem in classical statistical literature. In
such situation, the discrete point mass is modeled separately from the continuous part (see
[37, 39] and references therein). In our situation, it boils down to classification into sensi-
tive/resistive category followed by a regression in the sensitive category.
We have already demonstrated superiority of REFINED-CNN in both classification and
regression in Tables 6 and 10, respectively. In this section, we explore if REFINED-CNN’s
performance could be improved by synthetically oversampling the sensitive category to
arrive at a more balanced dataset [36]. To that end, we used a version of SMOTE technique
and generated bootstrap replicates from the sensitive category. The NRMSE and NMAE
(Normalized Mean Absolute Error) improvement of REFINED-CNN regression model on
different cell lines is illustrated in table 1. The bootstrap data augmentation systematically
decreases the NRMSE and NMAE for the cell lines indicating the negative impact of the
point mass in the response distribution.
Table 1: REFINED CNN NRMSE and NMAE improvement by data augmentation of the
sensitive drug region using bootstrap sampling.
No data augmentatoin Bootstrap
Cell Lines NRMSE NMAE # Samples NRMSE NMAE #Samples
SNB 78 0.784 0.713 13940 0.744 0.688 19613
MDA MB 435 0.787 0.739 36868 0.762 0.729 59570
NCI ADR RES 0.798 0.745 37156 0.755 0.717 59250
786 0 0.752 0.688 49344 0.713 0.663 76908
COLO 205 0.741 0.664 48946 0.722 0.660 75158
3.3.4 Sample Size Analysis
Deep CNN models are expected to perform better with larger number of samples as com-
pared to smaller number of samples. Therefore, we trained our model on different portion
of training sets for randomly selected cell lines to test this hypothesis. We trained our
model on 20 %, 40 %, 60 % and 80 % of the available drugs applied on the selected cell
lines and kept rest of the data for testing, considering NRMSE as a comparison metric. The
results of five cell lines are summarized in figure 7 which illustrates that REFINED-CNN
outperforms the other models as sample size increases. This trend was also observed on
the synthetic data (figure figure 4).
3.3.5 Model Stacking
To explore whether stacking of multiple models can improve prediction performance, we
stacked predicted drug sensitivity of the validation set of all models–in three different
combinations–as the covariates in a linear regression model to find the weight of each
model which are then employed to predict drug sensitivity of the test set. These three com-
binations are stacking non-CNN models (RF, SVR, ANN, and EN); stacking CNN models
(PCA CNN, Random CNN, and REFINED CNN); and stacking all models (REFINED
CNN and 6 other competitors). Figure 8 represents the stacking results where the average
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Figure 7: Comparison of six competing models with REFINED CNN for different training
sizes applied to five randomly selected cell lines of NCI60 dataset. The x-axis represents
the percentage of data used for training of each cell line along with the actual number of
samples used in brackets. To fit the figures, we shortened REFINED CNN as REFINED,
Random CNN as Random, and PCA CNN as CNN in the legends.
NRMSE of stacking all models is 0.738, stacking CNNs is 0.744 and stacking non-CNNs
0.837. By comparing the stacking results, with average NRMSE of each model in table
6 , the stacking produced a significant improvement as compared to non-CNN models in-
dividually. It is notable to mention that REFINED CNN average NRMSE in table 6 is
significantly lower than stacked of non-CNN models.
Figure 8: Comparison of stacking all models, all CNN models and non-CNN models using
NRMSE, bias and Pearson correlation coefficients (PCC).
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3.3.6 Bias Analysis
In this section, we re-investigate the effect of the REFINED-CNN approach on the bias
characteristics of the prediction using actual biological data. Figure 9 shows the plot of
the residuals against the observed values. Similar to the earlier presented synthetic data
scenario, Figure 9 (a) shows that REFINED-CNN has the lowest bias (20.2◦) as compared
to Random-CNN (32.8◦), PCA-CNN (23.8◦), ANN (29.2◦), RF (34.6◦), SVR (33.5◦) and
EN (43.1◦). To investigate whether bias correction erodes the advantage of REFINED-
CNN in terms of bias, we considered BC1 bias correction algorithm proposed in [29] where
we fit a second model (linear regression was used in this case) on the residuals. The results
shown in Figure 9 (b) illustrate the superiority of REFINED-CNN in terms of lowering bias
even after bias correction is applied to the competing models.
Figure 9: Residual plots for RF, SVR, EN, ANN, Random CNN, PCA CNN, and REFINED
CNN for SNB 78 cell line test set data prior bias correction (BC) (a) and post bias correction
(b). The corresponding NRMSE for scenario (a) are RF = 0.842, SVR = 0.847, EN = 0.964,
ANN = 0.822 , Random CNN = 0.864 , PCA CNN = 0.917, REFINED CNN = 0.784 and
for scenario (b) are RF = 0.830, SVR = 0.836, EN = 0.937, ANN = 0.817 , Random CNN
= 0.832 , PCA CNN = 0.840, REFINED CNN = 0.763.
3.4 GDSC dataset
In this section, we consider the application of REFINED CNN in integrating two types
of heterogeneous datasets. Our predictors now consist of (a) PaDel chemical descriptors
representing the drugs and (b) gene expression profiles for each cell line. The response
consists of the experimentally obtained IC50 for each drug-cell line pair. We used the
REFINED approach to generate the images corresponding to the gene expressions for each
cell line and drug descriptors for each drug compound in the GDSC dataset.
Considering 222 drugs and around 972 cell lines for each drug, the total number of
samples in the dataset is close to 177K. We randomly divided the dataset into 80% training,
10% validation and 10% test sets, where each set covariates contains 1211 genes and 992
chemical drug descriptors. Figure 10 represents the scatter plot of the natural log IC50 pre-
diction using our REFINED CNN approach, Random CNN, PCA CNN, ANN, RF, SVR,
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and EN along with their corresponding residual plots. Table 2 summarizes the performance
of each model using NRMSE, PCC, and bias.
Similar to NCI60 data analysis, we used Gap statistics and robustness analysis for fur-
ther comparison of the models. The robustness analysis and Gap statistics results are pro-
vided in tables 16 and 17 of the appendix respectively. The Gap statistics distribution plots
per each metric of each model paired with the null model along with their corresponding
cluster centroids are provided in figures 30-32 of the appendix.
As shown in table 2, REFINED-CNN model achieves improvement as compared to
other models in the range of 1-47% for NRMSE, 1-42%, for PCC. We also train the RE-
FINED CNN on 50% and 20% of the GDSC data and compared it with other competing
models. As the CNN architecture (please see figure 38 of the appendix) trained on the 80%
of the REFINED images was too complex to be trained on the 20% of the data, we reduced
the network complexity of REFINED CNN and ANN models. We removed the last con-
volutional layer and its latter dense layer for the CNN model, and also we removed the
first two dense layer of the ANN model. The detailed corresponding results are provided
in table 10. The predicted and residual scatter plots are provided in figures 28, 29 of the
appendix.
Table 2: Comparison of REFINED CNN, Random CNN, PCA CNN, ANN, RF, SVR, and
EN peformance on the GDSC dataset in terms of NRMSE, Pearson Correlation Coefficients
(PCC), and bias
Models
Trained on 20 % Trained on 50 % Trained on 80 %
NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias
EN 0.890 0.488 0.848 0.889 0.484 0.849 0.887 0.486 0.840
RF 0.609 0.797 0.433 0.620 0.785 0.417 0.569 0.821 0.337
SVR 0.750 0.847 0.257 0.742 0.845 0.273 0.525 0.853 0.241
ANN 1.407 0.519 0.784 0.475 0.883 0.153 0.435 0.901 0.233
Random CNN 0.579 0.836 0.215 0.456 0.892 0.193 0.441 0.903 0.222
PCA CNN 0.612 0.820 0.201 0.461 0.891 0.228 0.443 0.901 0.179
REFINED CNN 0.541 0.845 0.255 0.439 0.899 0.173 0.414 0.911 0.197
We also incorporated larger number of genes to experiment the impact of creating larger
images using REFINED. We selected larger common subset of genes including (2147 ∼
2000, 2985 ∼ 3000, 4271 ∼ 4000, 8048 ∼ 8000) genes and created the REFINED images
to train the same CNN architecture that we used to train the GDSC data with 1211 selected
genes. We also trained other competing models with the same hyper parameters. In our ex-
periment, the SVR model crashed after several hours due to the larger memory requirement
while estimating the kernel by computing the distance function between each point in the
dataset. Thus, we used a bag of SVRs, where we selected subset of 400 features (appended
gene expression and drug descriptors) to train 100 SVRs in parallel. The complete results
are provided in figure 33 and table 18 along with the corresponding confidence intervals
in figure 34 35 36 of the appendix. We observed that the trend of REFINED CNN outper-
forming other approaches is maintain irrespective of the number of genes used for training
models.
3.4.1 Comparison with state-of-the-art methods
We have also compared REFINED-CNN with another state-of-the-art approach, Deep-
Resp-Fores (DRF) proposed by Su et al. [48]. The DRF is a deep cascaded forest model,
designed to classify the anti-cancer drug response as “sensitive” or “resistive” based on in-
tegration of heterogeneous input data (gene expression and copy number alteration (CNA)
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Figure 10: Scatter plot of predicted NLOGIC50s and their residual (error) for each model,
in the case of models were trained on 80 % of the available data. In each scatter plot,
observation is the NLOGIC50 values if the test set. On the bottom row, bias of each model
is depicted by the method explained in the bias analysis section.
of GDSC data. We switched the random forest classifier of the DRF to a regressor for
prediction and used drug descriptors in the DRF’s wing that takes CNAs as the input for
training the DRF.
We have also compared REFINED-CNN with heterogeneous graph neural networks
(HGNN) proposed by Lim et al. [50]. HGNNs automate feature engineering task by ag-
gregating feature information of neighborhood nodes, where the input data of the network
are from different sources [49]. Lim’s network embeds the 3D structural information of
protein-ligand complexes in distance matrix, to predict drug-target interaction. We trained
their network by encompassing gene-drug information in distance matrix, to predict drug
sensitivity of the GDSC dataset. The results of applying DRF[48] and HGNN [50] are
provided in table 3 for comparing with REFINED CNN. As the results indicate, REFINED
CNN outperforms DRF and HGNN for drug response prediction of the GDSC dataset.
The robustness analysis and Gap statistics results for both DRF and HGNN methods are
provided in the table 16 and 17 of the appendix, respectively.
Table 3: Comparison REFINED-CNN with DRF and HGNN for GDSC drug sensitivity
prediction.
Models NRMSE PCC Bias
REFINED-CNN 0.414 0.911 0.197
DRF [48] 0.986 0.169 0.976
HGNN [50] 0.637 0.805 0.446
3.5 Ablation study
The main components of REFINED are dimensionality reduction followed by a search op-
timization algorithm, where we use Bayesian MDS as a global distortion minimizer and
hill climbing as local adjustment to reach a locally optimal configuration among multiple
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Figure 11: Barplots of REFINED ablation study on NCI regression task using three metrics:
NRMSE, PCC, and bias, where the bars show the CNN performance for different image
generation methods.
automorphs. To investigate the contribution of each individual component to REFINED,
evaluated the effect of different approaches in each step. For the dimensionality reduction
step, we considered other dimensionality reduction techniques such as Isomap [44], Lin-
ear Local Embedding (LLE) [45], and Laplacian Eigenmaps (LE) [46] instead of Bayesian
MDS. Isomap generalizes MDS with using Geodesic distance rather than Euclidean dis-
tance in nonlinear manifolds, where the Geodesic distance is approximated by summation
of Euclidean distances. LLE is a local dimensionality reduction technique, which tries to re-
construct each sample based on k-nearest samples in a lower dimension locally. Laplacian
eigenmap (LE) is similar to LLE except, it uses Laplacian graph to reconstruct k-nearest
neighbor, where k eigen vectors corresponding to the k smallest eigen values are preserved
for embedding [47].
To investigate the contribution of the search optimization algorithm, we initialized each
feature location randomly and applied the hill climbing methodology with the objective of
minimizing the difference between features Euclidean distance matrix in the initial domain
and the created REFINED image. We generated images using all the above-mentioned
methods and then trained the same CNN structure that we had used for NCI regression task
on the same cell lines. As an example, figure 12 shows created images using each described
method for one of the randomly selected drugs of the NCI dataset. Further examples are
provided through figures figs. 23 to 27 in the appendix.
The average results are numerically presented in table 4 and the pictorial representation
is included in figure 11 as barplots. As the results in the table 4 indicate, NRMSE associated
with REFINED initialized with Bayesian MDS is smaller than the NRMSE of all other
approaches. We observed that both global and local embedding do better than random
initialization followed by hill climbing. We also observed that the idea of non-overlapping
pixel locations for the features borne out by the hill climbing step improves the performance
if the dimensionality reduction approaches. Complete results of ablation study are provided
in table 14 and 15 of the appendix.
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Figure 12: Illustration of generated images of a randomly selected drug (NSC = 3069) of
NCI dataset, where the first row represent pattern of images generated only with different
initialization approach that included overlapping features and the second row shows the
REFINED images initialized with different dimensionality techniques followed by a hill
climbing step for avoiding overlap among features.
Table 4: Average results of REFINED ablation study on NCI regression task, where the
images are generated using different initialization methods with and without applying the
hill climbing component.
Initialization
No hill climbing REFINED
NRMSE PCC Bias NRMSE PCC Bias
Isomap 0.900 0.551 0.608 0.783 0.649 0.496
Bayesian MDS 0.858 0.582 0.616 0.776 0.647 0.481
LLE 0.956 0.424 0.780 0.802 0.632 0.512
LE 0.829 0.603 0.558 0.781 0.645 0.514
Random 0.884 0.554 0.659 0.849 0.578 0.605
4 Discussion
This paper presents a novel approach of converting high dimensional vectors into images
with spatial neighborhood dependency that can be used as inputs to traditional Convolu-
tional Neural Networks. The proposed methodology was conceived from the observation
that deep learning CNN has increased the prediction accuracy in many scenarios especially
when the inputs are images, but it is not usually appropriate when high dimensional vec-
tors with limited neighborhood correlations are used as inputs. Our REFINED approach
produces a mapping of the input features such that spatial neighbors are close and far away
points in the map are distant in initial feature space.
There are several advantages of the proposed REFINED methodology. First, the RE-
FINED mapping to a compact image space appears to allow for automated feature ex-
traction using deep learning CNN architecture. Using a synthetic dataset and altering
the amount of spurious features, we observed that REFIEND-CNN is able to significantly
outperform other approaches for scenarios with larger percentage of spurious features as
shown in figure 4.
Second, the REFINED CNN approach provides a gain in predictive accuracy as com-
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pared to other commonly used predictive models of Artificial Neural Networks, Random
Forest, Support vector Machines, and Elastic Net. We have validated the performance of
REFINED-CNN in (a) synthetic dataset, (b) NCI60 drug response dataset and (c) GDSC
dataset that combines chemical descriptors of drugs with genomic expressions of cell lines.
REFINED CNN also outperforms other state of the art methods such as Deep-Resp-Forest
and Heterogeneous graph models. REFINED CNN also outperforms other existing ap-
proaches in terms fo statistical significance and robustness.
Third, REFINED-CNN methodology can also be used to seamlessly combine hetero-
geneous predictors where each predictor can be mapped to an image as was done for the
GDSC prediction scenario. Perhaps the biggest advantage of REFINED-CNN is that it has
the potential to combine multi-type predictors, where some predictors are images, some
high dimensional vectors and some having functional forms. In principle, each type of pre-
dictor data can be individually mapped to images and the corresponding images can be used
as inputs in a CNN architecture. Finally, we observe that REFINED-CNN has better ability
to automatically perform bias correction as compared to ANN, RF and SVR as shown in
all three application scenarios (Figures 17, 9 and 10). The proposed REFINED approach
can also be used for data augmentation by using different realizations of the mapping as
was discussed in section 2.1.1. We have provided a theoretical justification to motivate how
the proposed approach can map to an ordering of features if such an ordering exists.
In terms of applications, the REFINED approach can be applied to any predictive mod-
eling scenario where the predictors are high dimensional vectors without an explicit neigh-
borhood based dependence structure. We motivated the application of the scenario through
the drug sensitivity prediction problem where both the gene expressions and chemical de-
scriptors are not necessarily ordered based on correlations.
Limitations of the approach will include scenarios where the covariance structure of
the features is primarily diagonal with limited correlations between any features. Further-
more, the REFINED approach is expected to benefit from the traditional CNN architecture
and thus the performance benefit will require large number of samples as is required for
normal CNN scenarios. Also note that, REFINED is a second order approximation under
Euclidean norm. If the predictor space is non-Euclidean, the current form of REFINED
will not be suitable.
To summarize, the paper presents a novel effective tool for feature representation and
multi-object regression and classification.
Data Availability
• NCI60: We downloaded the GI50 data from (https://dtp.cancer.gov/databases_
tools/bulk_data.htm) and the associated drug’s chemical information from (https:
//pubchem.ncbi.nlm.nih.gov/).
• GDSC: We downloaded the IC50 responses and cell line screened data from (https:
//www.cancerrxgene.org/downloads/bulk_download), and the drug’s chemi-
cal information from (https://pubchem.ncbi.nlm.nih.gov/).
• PaDel: To convert the chemical information of each drug to their descriptors, we
used (http://www.yapcwsoft.com/dd/padeldescriptor/) software.
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Code Availability
The code of this work will be available at https://github.com/omidbazgirTTU/REFINED.
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Appendix
A Syntethic dataset
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Figure 13: SVR’s NRMSE heatmap for different sample sizes and with different number
of features where the 20 %, 50 % and 80 % of the features are respectively spurious.
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Figure 14: RF’s NRMSE heatmap for different sample sizes and with different number of
features where the 20 %, 50 % and 80 % of the features are respectively spurious.
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Figure 15: ANN’s NRMSE heatmap for different sample sizes and with different number
of features where the 20 %, 50 % and 80 % of the features are respectively spurious.
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Figure 16: REFINED CNN’s NRMSE heatmap for different sample sizes and with different
number of features where the 20 %, 50 % and 80 % of the features are respectively spurious.
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(a) 4000 features with 80 % spurious rate, 600 samples
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(b) 4000 features with 20 % spurious rate, 600 samples
Figure 17: Prediction vs observation and Error vs observation of the simulated data for
REFINED CNN, ANN, RF, and SVR, where number of features, number of samples are
4000 and 600 respectively. spurious feature percentage for figure (a) is 80 % and for figure
(b) is 20 %. Note that the scatter plot for REFINED-CNN closely follows a straight line
with unit slope indicating predictive accuracy of our approach. RF and SVR reveal their
well-known tendency to under-predict higher valued observation and over-predict lower
valued observations. REFINED-CNN bias is also better than the bias observed for the
ANN scenario.
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B NCI60 dataset
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(a) Hold-out versus nested cross-validation pairwise comparison
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(b) Hold-out versus nested cross-validation trend comparison
Figure 18: Hold-out versus nested cross-validation: a) The pairwise comparison of the
models shows minimal difference between the two error estimation approaches. b) The
trend comparison indicates that the comparative performance of the models does not change
while using Hold-out and Nested-CV approaches. The cell lines that were selected ran-
domly from NCI60 dataset for this comparison are, CCRF CEM, MDA MB 435, and
SNB 78 with 47k, 37k and 14k number of drugs, respectively.
Table 5: Number of drugs applied on each selected cell line of the NCI60 dataset
Cell line CCRF CEM COLO 205 DU 145 EKVX HCC 2998 MDA MB 435 SNB 78 NCI ADR RES 786 0 A498 A549 ATCC ACHN BT 549 CAKI 1 DLD 1 DMS 114 DMS 273
#drugs (samples) 47571 49844 36622 47732 45192 36868 14006 37156 49453 43853 50703 49760 33466 47410 14650 14937 13728
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Table 6: Predicting sensitivity or resistivity of the drugs using seven classifiers part I, in-
cluding Random CNN, REFINED CNN, and PCA CNN
Cell lines
Random CNN REFIND CNN PCA CNN
Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC
CCRF CEM 0.725 0.723 0.725 0.723 0.716 0.752 0.751 0.752 0.75 0.743 0.721 0.72 0.721 0.717 0.708
COLO 205 0.748 0.748 0.748 0.748 0.748 0.762 0.762 0.762 0.762 0.762 0.734 0.734 0.734 0.734 0.734
DU 145 0.734 0.734 0.734 0.734 0.734 0.753 0.753 0.753 0.752 0.752 0.713 0.713 0.713 0.713 0.713
EKVX 0.713 0.713 0.713 0.713 0.712 0.747 0.748 0.747 0.747 0.747 0.709 0.709 0.709 0.708 0.707
HCC 2998 0.71 0.711 0.71 0.709 0.709 0.758 0.758 0.758 0.758 0.758 0.718 0.718 0.718 0.717 0.717
MDA MB 435 0.713 0.712 0.713 0.706 0.692 0.757 0.757 0.757 0.754 0.742 0.692 0.696 0.692 0.693 0.69
SNB 78 0.733 0.723 0.733 0.721 0.672 0.768 0.764 0.768 0.765 0.734 0.755 0.75 0.755 0.737 0.683
NCI ADR RES 0.707 0.712 0.707 0.708 0.708 0.771 0.771 0.771 0.771 0.768 0.714 0.714 0.714 0.711 0.702
786 0 0.72 0.72 0.72 0.72 0.72 0.764 0.764 0.764 0.764 0.764 0.713 0.714 0.713 0.713 0.713
A498 0.722 0.723 0.722 0.721 0.722 0.762 0.762 0.762 0.762 0.762 0.707 0.709 0.707 0.706 0.707
A549 ATCC 0.714 0.717 0.714 0.712 0.71 0.767 0.767 0.767 0.767 0.767 0.708 0.71 0.708 0.706 0.705
ACHN 0.698 0.701 0.698 0.697 0.698 0.745 0.747 0.745 0.745 0.745 0.706 0.707 0.706 0.706 0.706
BT 549 0.719 0.718 0.719 0.716 0.711 0.747 0.749 0.747 0.745 0.739 0.7 0.701 0.7 0.7 0.699
CAKI 1 0.714 0.714 0.714 0.714 0.714 0.755 0.759 0.755 0.754 0.755 0.716 0.719 0.716 0.715 0.715
DLD 1 0.722 0.717 0.722 0.695 0.642 0.779 0.775 0.779 0.775 0.745 0.734 0.728 0.734 0.716 0.666
DMS 114 0.681 0.682 0.681 0.674 0.669 0.736 0.737 0.736 0.733 0.727 0.683 0.688 0.683 0.673 0.668
DMS 273 0.705 0.701 0.705 0.698 0.679 0.704 0.704 0.704 0.691 0.669 0.762 0.76 0.762 0.76 0.747
Average 0.716 0.716 0.716 0.712 0.703 0.754 0.755 0.754 0.753 0.746 0.717 0.717 0.717 0.713 0.705
Table 7: Predicting sensitivity or resistivity of the drugs using seven classifiers part II,
including LR, RF, ANN, and SVM
Cell lines
LR RF SVM ANN
Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC
CCRF CEM 0.666 0.672 0.666 0.647 0.638 0.695 0.695 0.695 0.689 0.678 0.685 0.693 0.685 0.67 0.66 0.698 0.697 0.698 0.692 0.682
COLO 205 0.676 0.681 0.676 0.674 0.676 0.697 0.697 0.697 0.697 0.697 0.689 0.69 0.689 0.688 0.689 0.704 0.709 0.704 0.702 0.704
DU 145 0.672 0.681 0.672 0.665 0.667 0.698 0.699 0.698 0.698 0.697 0.687 0.69 0.687 0.685 0.685 0.707 0.709 0.707 0.706 0.708
EKVX 0.655 0.658 0.655 0.655 0.657 0.669 0.669 0.669 0.669 0.669 0.659 0.659 0.659 0.659 0.659 0.672 0.673 0.672 0.671 0.67
HCC 2998 0.662 0.667 0.662 0.661 0.663 0.69 0.69 0.69 0.69 0.69 0.688 0.689 0.688 0.688 0.689 0.705 0.708 0.705 0.704 0.705
MDA MB 435 0.682 0.687 0.682 0.664 0.65 0.699 0.698 0.699 0.691 0.677 0.694 0.699 0.694 0.678 0.663 0.706 0.705 0.706 0.7 0.687
SNB 78 0.735 0.736 0.735 0.704 0.644 0.755 0.75 0.755 0.74 0.687 0.732 0.748 0.732 0.689 0.627 0.742 0.741 0.742 0.716 0.656
NCI ADR RES 0.69 0.696 0.69 0.677 0.668 0.706 0.704 0.706 0.702 0.694 0.7 0.703 0.7 0.69 0.68 0.712 0.711 0.712 0.708 0.699
786 0 0.682 0.687 0.682 0.679 0.681 0.698 0.698 0.698 0.698 0.698 0.695 0.697 0.695 0.694 0.694 0.706 0.706 0.706 0.706 0.706
A498 0.673 0.678 0.673 0.671 0.673 0.701 0.701 0.701 0.701 0.701 0.695 0.697 0.695 0.694 0.695 0.707 0.716 0.707 0.704 0.707
A549 ATCC 0.678 0.68 0.678 0.678 0.679 0.708 0.707 0.708 0.707 0.707 0.699 0.699 0.699 0.699 0.699 0.713 0.713 0.713 0.713 0.712
ACHN 0.66 0.667 0.66 0.657 0.661 0.686 0.687 0.686 0.685 0.686 0.675 0.678 0.675 0.673 0.675 0.683 0.69 0.683 0.68 0.683
BT 549 0.673 0.687 0.673 0.656 0.654 0.702 0.705 0.702 0.697 0.691 0.692 0.705 0.692 0.678 0.674 0.7 0.711 0.7 0.689 0.684
CAKI 1 0.669 0.676 0.669 0.665 0.667 0.691 0.691 0.691 0.691 0.691 0.687 0.689 0.687 0.686 0.686 0.701 0.702 0.701 0.7 0.7
DLD 1 0.713 0.707 0.713 0.682 0.628 0.71 0.698 0.71 0.695 0.647 0.706 0.704 0.706 0.666 0.612 0.719 0.709 0.719 0.702 0.653
DMS 114 0.675 0.674 0.675 0.673 0.669 0.675 0.675 0.675 0.672 0.666 0.671 0.673 0.671 0.663 0.658 0.68 0.682 0.68 0.681 0.68
DMS 273 0.687 0.685 0.687 0.671 0.649 0.712 0.711 0.712 0.701 0.679 0.672 0.681 0.672 0.638 0.619 0.704 0.7 0.704 0.698 0.68
Average 0.679 0.683 0.679 0.669 0.66 0.7 0.699 0.7 0.695 0.685 0.69 0.694 0.69 0.679 0.668 0.703 0.705 0.703 0.698 0.689
Table 8: Comparing REFINED CNN classifier with 6 other competing classifiers using
McNemar’s test to discover statistical significance in predicted classes across selected cell
lines.
Cell lines LR RF SVM ANN Random CNN PCACNN
786 01 0 0 0 0 0 0
A4981 0 0 0 0 0 0
A549 ATCC1 0 0 0 0 0 0
ACHN1 0 0 0 0 0 0
BT 5491 5.1529E-231 7.0138E-192 1.5948E-204 5.6657E-219 1.0162E-261 2.0812E-258
CAKI 11 0 0 0 0 0 0
CCRF CEM1 9.5566E-299 2.4571E-237 1.0162E-261 0 0 0
COLO 2051 0 0 0 0 0 0
DLD 11 2.2132E-221 8.2447E-230 1.2882E-231 3.377E-226 4.2213E-227 1.0553E-227
DMS 1141 7.2835E-158 9.5467E-153 1.7782E-161 6.2565E-148 5.4267E-166 5.5569E-163
DMS 2731 5.7457E-188 3.5911E-189 3.4247E-195 3.0124E-182 7.8968E-177 1.9279E-180
DU 1451 1.424E-306 1.0912E-252 2.152E-283 0 0 0
EKVX1 0 0 0 0 0 0
HCC 29981 0 0 0 0 0 0
MDA MB 4351 2.2132E-221 7.1821E-189 1.6722E-198 1.2286E-237 1.9572E-295 4.203E-286
NCI ADR RES1 2.2347E-249 1.5209E-210 6.9161E-223 1.364E-253 8.2091E-289 2.1015E-286
SNB 781 1.6489E-229 1.5725E-235 1.9196E-239 5.0321E-234 3.377E-226 1.0064E-233
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Table 9: Predicting sensitivity or resistivity 95 % intervals of the drugs using seven classi-
fiers
Cell lines
Random CNN REFIND CNN PCA CNN LR RF SVM ANN
Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC Accuracy Precision Recall F1 Score AUC
CCRF CEM 0.038 0.038 0.038 0.038 0.039 0.037 0.037 0.037 0.037 0.038 0.039 0.039 0.039 0.039 0.039 0.041 0.040 0.041 0.041 0.041 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.041 0.039 0.039 0.039 0.040 0.040
COLO 205 0.037 0.037 0.037 0.037 0.037 0.037 0.037 0.037 0.037 0.037 0.038 0.038 0.038 0.038 0.038 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039
DU 145 0.038 0.038 0.038 0.038 0.038 0.037 0.037 0.037 0.037 0.037 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.041 0.041 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039
EKVX 0.039 0.039 0.039 0.039 0.039 0.037 0.037 0.037 0.037 0.037 0.039 0.039 0.039 0.039 0.039 0.041 0.041 0.041 0.041 0.041 0.040 0.040 0.040 0.040 0.040 0.041 0.041 0.041 0.041 0.041 0.040 0.040 0.040 0.040 0.040
HCC 2998 0.039 0.039 0.039 0.039 0.039 0.037 0.037 0.037 0.037 0.037 0.039 0.039 0.039 0.039 0.039 0.041 0.041 0.041 0.041 0.041 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039
MDA MB 435 0.039 0.039 0.039 0.039 0.040 0.037 0.037 0.037 0.037 0.038 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.041 0.041 0.039 0.039 0.039 0.040 0.040 0.040 0.039 0.040 0.040 0.041 0.039 0.039 0.039 0.039 0.040
SNB 78 0.038 0.038 0.038 0.039 0.040 0.036 0.036 0.036 0.036 0.038 0.037 0.037 0.037 0.038 0.040 0.038 0.038 0.038 0.039 0.041 0.037 0.037 0.037 0.038 0.040 0.038 0.037 0.038 0.040 0.042 0.038 0.038 0.038 0.039 0.041
NCI ADR RES 0.039 0.039 0.039 0.039 0.039 0.036 0.036 0.036 0.036 0.036 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.040 0.039 0.039 0.039 0.040 0.040 0.039 0.039 0.039 0.039 0.039
786 0 0.039 0.039 0.039 0.039 0.039 0.036 0.036 0.036 0.036 0.036 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039 0.040 0.039 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039
A498 0.039 0.038 0.039 0.039 0.039 0.037 0.037 0.037 0.037 0.037 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039 0.040 0.039 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039
A549 ATCC 0.039 0.039 0.039 0.039 0.039 0.036 0.036 0.036 0.036 0.036 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039 0.039 0.039 0.039 0.039 0.039 0.039 0.039 0.039 0.039 0.039
ACHN 0.039 0.039 0.039 0.039 0.039 0.037 0.037 0.037 0.037 0.037 0.039 0.039 0.039 0.039 0.039 0.041 0.041 0.041 0.041 0.041 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040
BT 549 0.039 0.039 0.039 0.039 0.039 0.037 0.037 0.037 0.037 0.038 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.041 0.041 0.039 0.039 0.039 0.039 0.040 0.040 0.039 0.040 0.040 0.040 0.039 0.039 0.039 0.040 0.040
CAKI 1 0.039 0.039 0.039 0.039 0.039 0.037 0.037 0.037 0.037 0.037 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.041 0.041 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.039
DLD 1 0.039 0.039 0.039 0.040 0.041 0.036 0.036 0.036 0.036 0.037 0.038 0.038 0.038 0.039 0.041 0.039 0.039 0.039 0.040 0.042 0.039 0.039 0.039 0.040 0.041 0.039 0.039 0.039 0.041 0.042 0.039 0.039 0.039 0.039 0.041
DMS 114 0.040 0.040 0.040 0.040 0.040 0.038 0.038 0.038 0.038 0.038 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.041 0.040 0.040 0.040 0.041 0.041 0.040 0.040 0.040 0.040 0.040
DMS 273 0.039 0.039 0.039 0.039 0.040 0.039 0.039 0.039 0.040 0.040 0.037 0.037 0.037 0.037 0.037 0.040 0.040 0.040 0.040 0.041 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.041 0.042 0.039 0.039 0.039 0.039 0.040
Average 0.039 0.039 0.039 0.039 0.039 0.037 0.037 0.037 0.037 0.037 0.039 0.039 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.041 0.039 0.039 0.039 0.040 0.040 0.040 0.040 0.040 0.040 0.040 0.039 0.039 0.039 0.039 0.040
Table 10: Drug sensitivity prediction using seven regression models. The NRMSE, PCC,
and bias of each model is used for comparison.
Cell lines
Random CNN PCA CNN REFINED CNN RF SVR ANN EN
NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias
CCRF CEM 0.868 0.536 0.818 0.884 0.529 0.671 0.774 0.653 0.493 0.893 0.465 0.839 0.874 0.521 0.750 0.828 0.563 0.705 0.978 0.259 0.973
COLO 205 0.958 0.538 0.709 0.823 0.601 0.564 0.741 0.686 0.448 0.892 0.467 0.837 0.867 0.535 0.746 0.811 0.587 0.680 0.974 0.288 0.968
DU 145 0.839 0.572 0.594 0.882 0.555 0.553 0.786 0.647 0.458 0.903 0.434 0.838 0.882 0.507 0.773 0.842 0.539 0.713 0.976 0.268 0.970
EKVX 0.867 0.553 0.579 0.894 0.572 0.514 0.804 0.618 0.535 0.904 0.433 0.842 0.881 0.503 0.769 0.848 0.530 0.713 0.978 0.252 0.972
HCC 2998 0.930 0.578 0.744 0.961 0.535 0.628 0.774 0.654 0.447 0.880 0.488 0.815 0.858 0.542 0.740 0.820 0.572 0.662 0.968 0.312 0.961
MDA MB 435 0.884 0.532 0.760 0.982 0.557 0.518 0.787 0.651 0.469 0.912 0.412 0.849 0.897 0.477 0.781 0.858 0.514 0.732 0.982 0.234 0.977
SNB 78 0.864 0.516 0.730 0.917 0.544 0.528 0.784 0.652 0.448 0.842 0.558 0.769 0.847 0.555 0.745 0.822 0.573 0.648 0.964 0.352 0.958
NCI ADR RES 0.945 0.470 0.751 0.834 0.580 0.565 0.798 0.638 0.475 0.908 0.434 0.860 0.903 0.476 0.799 0.857 0.518 0.737 0.984 0.275 0.981
786 0 0.877 0.558 0.604 0.944 0.599 0.543 0.752 0.665 0.450 0.887 0.481 0.832 0.878 0.521 0.767 0.832 0.571 0.707 0.974 0.289 0.968
A498 0.845 0.604 0.712 0.883 0.576 0.545 0.785 0.635 0.433 0.890 0.465 0.827 0.859 0.551 0.750 0.840 0.567 0.700 0.972 0.312 0.967
A549 ATCC 0.913 0.548 0.560 0.814 0.590 0.623 0.769 0.645 0.536 0.870 0.511 0.806 0.857 0.555 0.743 0.810 0.592 0.692 0.969 0.308 0.962
ACHN 0.830 0.571 0.616 0.837 0.562 0.732 0.747 0.665 0.560 0.880 0.494 0.822 0.868 0.529 0.759 0.816 0.585 0.675 0.975 0.284 0.970
BT 549 0.941 0.529 0.595 0.885 0.545 0.769 0.843 0.584 0.560 0.888 0.478 0.832 0.870 0.514 0.755 0.840 0.545 0.714 0.977 0.279 0.972
CAKI 1 0.866 0.561 0.589 0.886 0.475 0.753 0.775 0.640 0.423 0.901 0.444 0.845 0.885 0.507 0.773 0.863 0.537 0.692 0.982 0.241 0.977
DLD 1 0.923 0.620 0.611 0.812 0.584 0.666 0.781 0.625 0.499 0.847 0.557 0.783 0.867 0.529 0.763 0.824 0.568 0.667 0.975 0.270 0.968
DMS 114 0.873 0.546 0.575 0.953 0.565 0.487 0.738 0.680 0.484 0.832 0.568 0.746 0.834 0.571 0.689 0.804 0.596 0.631 0.985 0.332 0.958
DMS 273 0.810 0.587 0.652 0.909 0.586 0.619 0.758 0.670 0.454 0.829 0.568 0.735 0.860 0.538 0.728 0.817 0.578 0.645 0.984 0.318 0.955
Average 0.884 0.554 0.659 0.888 0.562 0.605 0.776 0.647 0.481 0.880 0.486 0.816 0.870 0.525 0.755 0.831 0.561 0.689 0.976 0.287 0.968
Table 11: Robustness analysis to compare REFINED CNN with 6 other competing models
per each metric and each cell line. Each cell of the table represents the percentage for
which REFINED CNN outperforms the paired competing model.
Cell lines
REFIEND CNN Versus PCA CNN REFIEND CNN Versus Random CNN REFIEND CNN Versus ANN REFIEND CNN Versus SVR REFIEND CNN Versus RF REFIEND CNN Versus EN
NRMSE Percentage PCC Percentage Bias Percentage NRMSE Percentage PCC Percentage Bias Percentage NRMSE Percentage PCC Percentage Bias Percentage NRMSE Percentage PCC Percentage Bias Percentage NRMSE Percentage PCC Percentage Bias Percentage NRMSE Percentage PCC Percentage Bias Percentage
786 0 100 94.3 81.5 99.9 99.7 95.2 99.3 98.7 100 100 100 100 100 100 100 100 100 100
A498 99.8 91.8 95.4 100 100 100 96.8 96.1 99.8 99.5 98.1 100 100 100 100 100 100 100
A549 ATCC 88.8 90.3 98.4 100 98.1 72.9 87.7 88.6 100 99.6 98.3 100 99.8 99.9 100 100 100 100
ACHN 99.8 99 100 99.2 98.9 93.7 98.8 97.9 99.7 100 99.8 100 100 100 100 100 100 100
BT 549 88.3 80.6 100 98.9 91.9 81.8 45 83.6 100 80.2 95.2 100 91.2 99.2 100 100 100 100
CAKI 1 99.8 100 100 100 95.2 100 99.5 99.5 100 100 99.9 100 100 100 100 100 100 100
DLD 1 78.1 78.1 88.4 100 98.8 100 91.5 90.8 99.4 99.9 98.7 100 100 100 100 100 100 100
DMS 114 100 99.3 51.8 100 100 100 98.8 99.1 100 100 100 100 100 100 100 100 100 100
DMS 273 100 97.6 100 99.9 87.4 82 94.3 99.2 100 99.6 99.8 100 98.9 98.9 100 100 100 100
HCC 2998 100 99.7 68.7 99.5 98.9 95.3 79.2 89.7 82.4 96.1 96.9 99.4 96.8 97.2 100 100 100 100
CCRF CEM 100 99.9 100 84 94 100 88.5 95.5 100 99.8 99.6 100 94.8 97.1 100 100 100 100
COLO 205 95.1 93.7 99.8 99.4 99.6 100 99.8 100 100 100 100 100 100 100 100 100 100 100
DU 145 98.8 99 98.8 100 100 100 96.4 99.9 100 99.8 100 100 99.8 100 100 100 100 100
EKVX 96.9 85 91.6 100 80.1 100 67.3 86.7 100 93.1 96.2 100 98.6 99.8 100 100 100 100
MDA MB 435 100 99.9 87.7 99.8 100 100 98.9 100 100 99.9 100 100 100 100 100 100 100 100
NCI ADR RES 98 98.9 98.7 100 100 100 97.1 100 100 100 100 100 100 100 100 100 100 100
SNB 78 99.3 98 88.5 96.7 99.4 100 82.7 94.5 100 92 97 100 91.3 96.8 100 100 100 100
Average 96.63 94.42 91.14 98.66 96.59 95.35 89.51 95.28 98.90 97.62 98.79 99.96 98.31 99.35 100.00 100.00 100.00 100.00
Table 12: Gap statistics analysis to compare REFINED CNN with 6 other competing mod-
els per each metric and each cell line paired with the null model. The wider (larger) Gap
value indicates better performance.
Cell lines
REFINED CNN Gap PCA CNN Gap Random CNN Gap RF Gap SVR Gap ANN Gap EN Gap
NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias
786 0 0.735 0.661 0.468 0.544 0.593 0.565 0.604 0.554 0.407 0.598 0.481 0.407 0.611 0.520 0.241 0.652 0.566 0.301 0.478 0.095 0.145
A498 0.699 0.630 0.400 0.597 0.570 0.468 0.501 0.469 0.588 0.592 0.462 0.588 0.628 0.549 0.260 0.640 0.562 0.309 0.477 0.327 0.039
A549 ATCC 0.716 0.641 0.479 0.668 0.585 0.389 0.564 0.541 0.453 0.615 0.507 0.453 0.631 0.552 0.265 0.676 0.588 0.319 0.477 0.179 0.037
ACHN 0.730 0.658 0.450 0.641 0.556 0.274 0.647 0.567 0.396 0.596 0.490 0.396 0.612 0.525 0.250 0.661 0.580 0.334 0.471 0.222 0.036
BT 549 0.806 0.581 0.454 0.616 0.548 0.235 0.555 0.529 0.422 0.613 0.477 0.422 0.633 0.514 0.253 0.660 0.541 0.294 0.495 0.283 0.029
CAKI 1 0.708 0.635 0.483 0.597 0.476 0.254 0.595 0.571 0.591 0.583 0.445 0.591 0.602 0.506 0.234 0.618 0.534 0.315 0.477 0.222 0.140
DLD 1 0.710 0.622 0.403 0.676 0.580 0.348 0.609 0.522 0.190 0.594 0.462 0.190 0.617 0.519 0.256 0.663 0.558 0.301 0.476 0.320 0.143
DMS 114 0.764 0.673 0.530 0.555 0.562 0.535 0.633 0.513 0.300 0.608 0.464 0.300 0.638 0.533 0.263 0.693 0.583 0.327 0.492 0.288 0.168
DMS 273 0.725 0.667 0.561 0.563 0.581 0.397 0.557 0.610 0.513 0.631 0.555 0.513 0.618 0.530 0.251 0.656 0.565 0.348 0.470 0.331 0.029
HCC 2998 0.713 0.648 0.417 0.521 0.529 0.401 0.607 0.540 0.441 0.654 0.566 0.441 0.655 0.569 0.326 0.681 0.591 0.384 0.481 0.077 0.029
RF CEM 0.711 0.649 0.521 0.601 0.529 0.341 0.672 0.582 0.361 0.653 0.568 0.361 0.628 0.544 0.285 0.666 0.576 0.370 0.479 0.244 0.134
OLO 205 0.727 0.681 0.562 0.661 0.621 0.446 0.625 0.567 0.417 0.564 0.437 0.417 0.588 0.507 0.233 0.625 0.536 0.294 0.461 0.243 0.132
DU 145 0.708 0.643 0.556 0.612 0.551 0.462 0.605 0.470 0.153 0.591 0.435 0.153 0.618 0.499 0.240 0.647 0.526 0.296 0.490 0.318 0.150
EKVX 0.684 0.613 0.475 0.591 0.567 0.501 0.557 0.579 0.258 0.606 0.481 0.258 0.634 0.538 0.266 0.668 0.567 0.344 0.481 0.296 0.140
MDA MB 435 0.699 0.647 0.545 0.403 0.509 0.496 0.604 0.531 0.245 0.572 0.409 0.245 0.593 0.476 0.228 0.627 0.511 0.274 0.481 0.329 0.138
NCI ADR RES 0.701 0.633 0.537 0.621 0.541 0.448 0.554 0.472 0.259 0.593 0.434 0.259 0.602 0.476 0.210 0.644 0.516 0.269 0.494 0.428 0.147
SNB 78 0.716 0.649 0.575 0.568 0.539 0.496 0.633 0.526 0.297 0.653 0.554 0.297 0.656 0.556 0.276 0.672 0.568 0.371 0.479 0.282 0.183
Average 0.721 0.643 0.495 0.590 0.555 0.415 0.596 0.538 0.370 0.607 0.484 0.370 0.622 0.524 0.255 0.656 0.557 0.321 0.480 0.264 0.107
Table 13: REFINED on different training size for randomly selected five cell lines
CCRF CEM EKVX MDA MB 435 NCI ADR RES SNB 78
Training size NRMSE PCC NRMSE PCC NRMSE PCC NRMSE PCC NRMSE PCC
20 % 1.279 0.373 0.899 0.4980 0.949 0.454 0.953 0.464 0.876 0.537
40 % 0.985 0.478 0.881 0.511 0.911 0.494 0.958 0.536 0.825 0.590
60 % 0.903 0.538 0.849 0.525 0.839 0.575 0.857 0.528 0.806 0.591
80 % 0.774 0.653 0.804 0.618 0.787 0.651 0.798 0.638 0.784 0.652
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(c) NRMSEs of A549 ATCC cell line
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(d) PCCs of A549 ATCC cell line
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(e) NRMSEs of DMS 273 cell line
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(f) PCCs of DMS 273 cell line
Figure 19: Distribution of NRMSEs and PCCs metric of all seven models drawn from the
Gap statistics test for three cell lines of the NCI60 dataset. The distributions clustered
into two groups and their associated cluster centroids are shown with a vertical bar on the
histogram plots.
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Figure 20: NRMSE with 95 % confidence interval of each model trained on 17 cell lines
of NCI60 dataset, reported for each cell line per model separately.
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Figure 21: PCC with 95 % confidence interval of each model trained on 17 cell lines of
NCI60 dataset, reported for each cell line per model separately.
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Figure 22: Bias with 95 % confidence interval of each model trained on 17 cell lines of
NCI60 dataset, reported for each cell line per model separately.
Figure 23: First row: Images created using different dimensionality reduction techniques.
Second row: Images created using REFINED initialized with different dimensionality re-
duction techniques. Corresponding NSC = 1
37
Figure 24: First row: Images created using different dimensionality reduction techniques.
Second row: Images created using REFINED initialized with different dimensionality re-
duction techniques. Corresponding NSC = 171
Figure 25: First row: Images created using different dimensionality reduction techniques.
Second row: Images created using REFINED initialized with different dimensionality re-
duction techniques. Corresponding NSC = 377
38
Figure 26: First row: Images created using different dimensionality reduction techniques.
Second row: Images created using REFINED initialized with different dimensionality re-
duction techniques. Corresponding NSC = 740
Figure 27: First row: Images created using different dimensionality reduction techniques.
Second row: Images created using REFINED initialized with different dimensionality re-
duction techniques. Corresponding NSC = 5554
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Table 14: Results of training CNN on the images created from NCI60 dataset using differ-
ent dimensionality reduction techniques explained in the Ablation study.
Cell line
Isomap LLE MDS LE Random
NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias
CCRF CEM 0.962 0.470 0.701 0.980 0.233 0.963 0.831 0.622 0.667 0.797 0.614 0.561 0.868 0.536 0.818
COLO 205 0.891 0.584 0.514 1.262 0.000 1.000 0.787 0.622 0.59 0.785 0.641 0.483 0.958 0.538 0.709
DU 145 0.868 0.507 0.724 0.979 0.406 0.835 0.864 0.592 0.523 0.806 0.614 0.533 0.839 0.572 0.594
EKVX 0.853 0.572 0.665 1.021 0.397 0.812 0.867 0.545 0.587 0.841 0.570 0.574 0.867 0.553 0.579
HCC 2998 0.830 0.565 0.630 0.832 0.591 0.562 0.825 0.628 0.467 0.929 0.550 0.545 0.93 0.578 0.744
MDA MB 435 0.911 0.453 0.773 0.922 0.499 0.643 1.019 0.429 0.748 0.821 0.586 0.632 0.884 0.532 0.76
SNB 78 0.828 0.576 0.598 0.859 0.519 0.754 0.819 0.588 0.684 0.817 0.585 0.684 0.864 0.516 0.73
NCI ADR RES 1.315 0.470 0.481 0.895 0.474 0.793 0.938 0.488 0.746 0.824 0.576 0.616 0.945 0.47 0.751
786 0 0.820 0.602 0.546 0.827 0.574 0.677 0.814 0.647 0.66 0.852 0.618 0.477 0.877 0.558 0.604
A498 0.892 0.573 0.534 1.018 0.045 0.998 0.844 0.582 0.681 0.797 0.618 0.537 0.845 0.604 0.712
A549 ATCC 0.801 0.614 0.557 0.851 0.559 0.724 0.896 0.599 0.765 0.825 0.631 0.470 0.913 0.548 0.56
ACHN 1.109 0.494 0.602 0.914 0.462 0.815 0.789 0.631 0.514 0.900 0.601 0.449 0.83 0.571 0.616
BT 549 0.850 0.530 0.701 0.890 0.465 0.768 0.926 0.499 0.764 0.835 0.562 0.624 0.941 0.529 0.595
CAKI 1 0.874 0.548 0.649 1.439 0.376 0.781 0.935 0.546 0.546 0.799 0.609 0.569 0.866 0.561 0.589
DLD 1 0.880 0.587 0.531 0.902 0.468 0.829 0.786 0.629 0.533 0.792 0.636 0.652 0.923 0.62 0.611
DMS 114 0.830 0.577 0.599 0.854 0.539 0.709 0.847 0.619 0.467 0.898 0.602 0.503 0.873 0.546 0.575
DMS 273 0.780 0.639 0.529 0.813 0.598 0.588 0.801 0.62 0.52 0.771 0.639 0.579 0.81 0.587 0.652
Average 0.900 0.551 0.608 0.956 0.424 0.780 0.858 0.582 0.616 0.829 0.603 0.558 0.884 0.554 0.659
Table 15: Results of training CNN on the images created from NCI60 dataset using RE-
FINED initialized with different dimensionality reduction techniques explained in the Ab-
lation study.
Cell line
REFINED Isomap REFINED LLE REFINED MDS REFINED LE REFINED Random
NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias
CCRF CEM 0.799 0.630 0.498 0.781 0.638 0.515 0.774 0.653 0.493 0.790 0.633 0.510 0.816 0.586 0.725
COLO 205 0.752 0.673 0.493 0.765 0.652 0.509 0.741 0.686 0.448 0.782 0.658 0.433 0.812 0.606 0.662
DU 145 0.858 0.628 0.443 0.825 0.613 0.531 0.786 0.647 0.458 0.822 0.621 0.595 0.935 0.518 0.604
EKVX 0.790 0.634 0.504 0.839 0.587 0.526 0.804 0.618 0.535 0.824 0.601 0.622 0.998 0.528 0.580
HCC 2998 0.758 0.668 0.456 0.834 0.623 0.465 0.774 0.654 0.447 0.772 0.660 0.451 0.833 0.608 0.454
MDA MB 435 0.817 0.622 0.495 0.893 0.574 0.688 0.787 0.651 0.469 0.824 0.609 0.559 0.811 0.627 0.586
SNB 78 0.827 0.636 0.436 0.831 0.626 0.458 0.784 0.652 0.448 0.755 0.661 0.547 0.846 0.542 0.778
NCI ADR RES 0.791 0.632 0.517 0.823 0.603 0.583 0.798 0.638 0.475 0.811 0.608 0.547 0.810 0.542 0.593
786 0 0.751 0.678 0.504 0.763 0.663 0.467 0.752 0.665 0.450 0.756 0.672 0.451 0.784 0.637 0.661
A498 0.799 0.624 0.508 0.785 0.662 0.435 0.785 0.635 0.433 0.789 0.633 0.569 0.787 0.631 0.669
A549 ATCC 0.754 0.673 0.472 0.779 0.650 0.465 0.769 0.645 0.536 0.750 0.675 0.469 0.858 0.556 0.473
ACHN 0.768 0.684 0.526 0.766 0.656 0.503 0.747 0.665 0.560 0.756 0.659 0.530 0.922 0.585 0.551
BT 549 0.812 0.594 0.583 0.821 0.606 0.521 0.843 0.584 0.560 0.801 0.609 0.585 0.822 0.591 0.708
CAKI 1 0.785 0.639 0.491 0.817 0.590 0.608 0.775 0.640 0.423 0.816 0.617 0.510 0.836 0.571 0.666
DLD 1 0.729 0.687 0.506 0.821 0.622 0.527 0.781 0.625 0.499 0.750 0.680 0.433 0.832 0.594 0.537
DMS 114 0.764 0.671 0.510 0.736 0.690 0.431 0.738 0.680 0.484 0.749 0.676 0.467 0.857 0.563 0.576
DMS 273 0.754 0.667 0.492 0.752 0.693 0.478 0.758 0.670 0.454 0.722 0.701 0.453 0.866 0.546 0.463
Average 0.783 0.649 0.496 0.802 0.632 0.512 0.776 0.647 0.481 0.781 0.645 0.514 0.849 0.578 0.605
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Figure 28: Scatter plot of predicted NLOGIC50s and their residual (error) for each model,
in the case where models were trained on 50 % of the available data
Figure 29: Scatter plot of predicted NLOGIC50s and their residual (error) for each model,
in the case where models were trained on 20 % of the available data
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Table 16: Robustness analysis to compare REFINED CNN with 8 other competing models
per each metric. Each cell of the table represents that in what percentage REFINED CNN
outperforms the paired competing model.
Comparison NRMSE PCC Bias
REFINED CNN vs ANN 62.23 60.68 73.49
REFINED CNN vs RF 98.39 98.19 97.95
REFINED CNN vs SVR 93.83 93.36 73.47
REFINED CNN vs EN 100 100 100
REFINED CNN vs PCA CNN 66.58 62.04 68.85
REFINED CNN vs Random CNN 65.78 69.77 65.27
REFINED CNN vs DRF 100 100 100
REFINED CNN vs HGNN 99.87 98.81 99.99
Table 17: Gap statistics analysis to compare REFINED CNN with 8 other competing mod-
els per each metric paired with the null model. The wider (larger) Gap value indicates
better performance.
Model NRMSE PCC Bias
REFINED CNN 1.010 0.902 0.853
PCA CNN 0.980 0.892 0.871
Random CNN 0.983 0.895 0.828
RF 0.852 0.812 0.710
SVR 0.898 0.844 0.808
ANN 0.988 0.893 0.815
EN 0.535 0.476 0.200
DRF 0.432 0.184 0.120
HGNN 0.782 0.792 0.550
Table 18: Detailed results of modeling GDSC dataset using different number of genes.
Metrics
1k Genes 2k Genes 3k Genes 4k Genes 8k Genes
NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias NRMSE PCC Bias
EN 0.887 0.487 0.840 0.886 0.488 0.836 0.885 0.490 0.835 0.884 0.491 0.833 0.883 0.493 0.833
RF 0.570 0.822 0.337 0.622 0.784 0.414 0.622 0.784 0.414 0.622 0.784 0.414 0.623 0.783 0.414
SVR 0.525 0.854 0.241 0.572 0.836 0.340 0.574 0.835 0.341 0.594 0.822 0.363 0.660 0.774 0.458
ANN 0.436 0.902 0.233 0.442 0.898 0.162 0.440 0.899 0.169 0.444 0.897 0.166 0.441 0.898 0.201
Random CNN 0.441 0.903 0.222 0.392 0.921 0.179 0.385 0.923 0.143 0.384 0.924 0.156 0.413 0.911 0.198
PCA CNN 0.443 0.901 0.179 0.401 0.918 0.181 0.400 0.918 0.207 0.395 0.922 0.163 0.425 0.909 0.237
REFINED CNN 0.414 0.911 0.197 0.381 0.925 0.163 0.388 0.922 0.148 0.377 0.927 0.169 0.402 0.917 0.206
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Figure 30: Distribution of NRMSEs of all nine models drawn from the Gap statistics test of
the GDSC dataset. The distributions clustered into two groups and their associated cluster
centroids are shown with a vertical bar on the histogram plots.
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Figure 31: Distribution of PCCs of all nine models drawn from the Gap statistics test of
the GDSC dataset. The distributions clustered into two groups and their associated cluster
centroids are shown with a vertical bar on the histogram plots.
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Figure 32: Distribution of Biases of all nine models drawn from the Gap statistics test of
the GDSC dataset. The distributions clustered into two groups and their associated cluster
centroids are shown with a vertical bar on the histogram plots.
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Figure 33: Modeling GDSC dataset using different number of genes.
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Figure 34: NRMSE with 95 % confidence interval of each model trained on GDSC dataset.
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Figure 35: PCC with 95 % confidence interval of each model trained on GDSC dataset.
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Figure 36: Bias with 95 % confidence interval of each model trained on GDSC dataset
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D REFINED CNN architectures
Figure 37: The architecture of the CNN models used to train the NCI60 dataset (left model
is the CNN regressor, right model is the CNN classifier). Plot created by ’graphviz’ utility
of keras [55].
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Figure 38: The architecture of the CNN model used to train the GDSC dataset. Plot created
by ’graphviz’ utility of keras [55].
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